PGEN vs ZBH · rev $9.7M vs P/E 23, rev $4.26B
Precigen Inc (PGEN) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported PGEN revenue for 2025-12-31 was $9.7M. Net income was -$250.6M. PGEN currently screens at market cap $419.2M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
PGEN currently screens at market cap $419.2M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the PGEN and ZBH stock pages for the full models.
Not investment advice.